| Target Price | $20.40 |
| Price | $6.31 |
| Potential |
223.30%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Precision BioSciences, Inc. 2027 .
The average Precision BioSciences, Inc. target price is $20.40.
This is
223.30%
register free of charge
$63.00
898.42%
register free of charge
$18.18
188.11%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Precision BioSciences, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Precision BioSciences, Inc. stock has an average upside potential 2027 of
223.30%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 34.26 | 13.21 |
| 50.13% | 61.45% | |
| EBITDA Margin | -147.93% | -510.50% |
| 333.56% | 245.10% | |
| Net Margin | -133.45% | -738.52% |
| 1,378.66% | 453.41% |
7 Analysts have issued a sales forecast Precision BioSciences, Inc. 2026 . The average Precision BioSciences, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Precision BioSciences, Inc. EBITDA forecast 2026. The average Precision BioSciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Precision BioSciences, Inc. Analysts have issued a net profit forecast 2026. The average Precision BioSciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.56 | -3.69 |
| 442.31% | 3.65% | |
| P/E | negative | |
| EV/Sales | 8.26 |
7 Analysts have issued a Precision BioSciences, Inc. forecast for earnings per share. The average Precision BioSciences, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Precision BioSciences, Inc....
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jun 09 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 27 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jun 09 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 27 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


